RFNCX
Price
$88.18
Change
+$0.80 (+0.92%)
Updated
Jul 3 closing price
Net Assets
153.19B
VITSX
Price
$150.04
Change
+$1.28 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

RFNCX vs VITSX

Header iconRFNCX vs VITSX Comparison
Open Charts RFNCX vs VITSXBanner chart's image
American Funds Fundamental Invs R3
Price$88.18
Change+$0.80 (+0.92%)
VolumeN/A
Net Assets153.19B
Vanguard Total Stock Market Idx I
Price$150.04
Change+$1.28 (+0.86%)
VolumeN/A
Net Assets1.82T
RFNCX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RFNCX vs. VITSX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RFNCX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. RFNCX (153B). VITSX pays higher dividends than RFNCX: VITSX (1.22) vs RFNCX (0.66). RFNCX was incepted earlier than VITSX: RFNCX (23 years) vs VITSX (28 years). RFNCX (0.92) is less costly to investors than VITSX (0.03). RFNCX is a more actively managed with annual turnover of: 28.00 vs. VITSX (2.00). RFNCX has a lower initial minimum investment than VITSX: RFNCX (250) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 13.90 vs. RFNCX (8.27). VITSX return over 5 years is better than : 95.64 vs. RFNCX (56.86).
RFNCXVITSXRFNCX / VITSX
Total Expense Ratio0.920.033,067%
Annual Report Gross Expense Ratio0.920.033,067%
Fund Existence23 years28 years-
Gain YTD9.8916.423154%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets153B1.82T8%
Annual Yield % from dividends0.661.2254%
Returns for 1 year8.2713.9060%
Returns for 3 years52.2662.1284%
Returns for 5 years56.8695.6459%
Returns for 10 years72.57198.6437%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.250.01
+3.14%
Adaptimmune Therapeutics plc
CROX107.340.60
+0.56%
Crocs
ALTI4.140.01
+0.24%
AlTi Global
HRMY32.160.05
+0.16%
Harmony Biosciences Holdings
XOMAP25.420.01
+0.03%
XOMA Corp